Clinical Pharmacy 2019
The Euroscicon is welcoming for Conference on Clinical and Hospital Pharmacy 2019. On The topic of the current year's gathering is Developmental Strategies and Uptake of Clinical and Hospital Pharmacy which will give a worldwide stage to talk of present and future of Pharmacy. The extension of two committed streams for the EuroSiCon Conference on Pharmacy 2019gathering was a hit we could get learning from two specific gathering one that surpassed desires in the deliberate and collecting end and one that surpassed desires in the business and key end.
The 2019 foundation of this gathering will empower us to continue plunging further into both the examination of Biosimilar change and the business necessities for associations.
The Organizing Committee is satisfied to welcome you to attend the EuroSiCon Conference on Pharmacy; one of its astonishing Pharmaceutical gatherings on Pharmacy joins scientists, authorities and CROs from around the world. Various Biologics things are affecting their passage in the pharma to publicise and experiencing a striking climb in their utilization over the standard remedies.
At Pharmacy 2019 meet your planned intrigue bunches from around the world focused on getting some answers concerning Clinical and Hospital. This gathering would be your single most obvious opportunity to accomplish the greatest accumulation of individuals from the Clinical and Hospital Pharmacy gathering.
Why to Attend?
Join your companions the world over focused on getting some answers concerning Clinical and Hospital Pharmacy related advances, which is your single most obvious opportunity to accomplish the greatest gathering of individuals from the Pharma society, coordinate shows, scatter information, meet with recurring pattern and potential specialists, make a sprinkle with new research works, and get name affirmation at this Two-day event. Broadly acclaimed speakers, the most recent research, moves, and the most momentum refreshes in Clinical and Hospital Pharmacy are indications of this gathering. Provision of information on new technologies implemented in the field of Pharmacy and a sound knowledge on the Clinical Trail development. Provides interaction with the world's well known CEO's and Directors of the Pharmaceutical companies.
Benefits to attend Pharmacy 2019:
a) Keynote introduction alongside connections to excite established researchers.
c) A wide track of exhibitors to grandstand the new and rising advancements
d) Platform to worldwide speculation group to interface with partners in Pharmacy area
e) Links to the political promoting assets keeping in mind the end goal to extend your business and research organize
f) Triumph of Awards, Certificates perceives your sense of duty regarding your calling to empower the incipient research.
Pharmacy 2019 Benefits:
• Open board exchanges: Providing an open gathering with specialists from the scholarly world and business to talk about on current difficulties in Clinical and Hospital Pharmacy, where all participants can collaborate with the board took after by a Q&A session.
• Speaker and notice introductions: Providing a stage to all academicians and industry experts to share their exploration contemplations and discoveries through a discourse or a publication introduction.
• Editorial executive gathering: Discussing on development and advancement of open access Clinical and Hospital Pharmacy International Journals and enlisting board individuals and analysts who can bolster the diary.
• Round table gatherings: Providing a stage where industry experts meet scholastic specialists.
• Executives, CEO's of Organizations
• Business Development Managers
• Boss Scientific Officers
• Research and development Researchers from Clinical and Hospital Pharmacy Industries
• Educators, Associate Professors, Assistant Professors
• PhD Scholars
• Patent Attorneys
• Protected innovation Attorneys
• Speculation Analysts
•Affiliation, Association presidents and experts
• Honourable laureates in Health Care and Medicine
• Bio instruments Professionals
• Bio-informatics Professionals
• Programming improvement organizations
• Research Institutes and individuals
• Inventory network organizations
• Assembling Companies
• CRO (Contract Research Organization) and DATA administration Companies
• Preparing Institutes
• Business Entrepreneurs
Track 1: Clinical And Hospital Pharmacy:
Clinical and hospital pharmacy deals with the application of drug treatments to patients in a hospital or clinical setting. The study of pharmacy involves the effective recommendation and administration of various medications for the safety and health of patients. Clinical or hospital pharmacy is a specialization of this field that includes additional duties such as aiding doctors in applying drug therapies. Typically, pharmacology students can choose to specialize in this area during their residency program
The global Pharmacy Automation market is valued at 9140 million US$ in 2017 and will reach 20800 million US$ by the end of 2025, growing at a CAGR of 10.8% during 2018-2025.
Track 2: Pharma Research & Development:
Research & Development is essential in all industries. And, when it comes to the Biopharmaceutical research industry, R&D services not only generates income for the companies involved in the research but it often brings results in lives being saved, or at least enhancement in patient's lives. The development for many companies requires the perfect Pharmaceutical research & development. There has been a great deal of research and development in this industry by the doctors and scientists all over the world. Reliable Pharmaceutical R&D services allow companies to follow manufacturing procedures, quality control measures being taken, production scope and technical know-how
Global pharmaceutical research and development (R&D) spending from 2010-2024 in billion U.S. dollars. In 2016, the pharmaceutical industry spent some 159 billion U.S. dollars on research and development. To some estimation, this figure should increase to over 200 billion dollars in 2024.
Clinical pharmacy is the branch of pharmacy in which doctor of pharmacy provide patient care that optimizes the use of medication and promotes health, wellness, and disease prevention, Clinical pharmacists have an opportunity to reduce health-care costs and improve disease management as patients transition from inpatient to outpatient care by leading interventions to develop patient care plans, educate patients and clinicians, prevent adverse drug reactions, reconcile medications, monitor drug levels, and improve medication access and adherence. Through these methods, clinical pharmacists are able to reduce rates of hospitalization, readmission, and mortality
According to IMS Health Consulting, an international research company, in 2012 the size of the global pharmaceutical market reached $940 billion. In monetary terms it grew by 6%. In the future the sector is expected to grow at no less than 3% to 4% a year and if this happens the global pharmaceutical market is expected to reach $1.1 trillion by 2015 and will reach $1.2 trillion in 2016 and up to $1.5 trillion by 2020. The global demographic, epidemiological and economic changes are transforming the pharmaceutical market
Track 4: Clinical Drug Development And Drug Reactions :
Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.
An adverse drug reaction (ADR) is an injury caused by taking a medication. ADRs may occur following a single dose or prolonged administration of a drug or result from the combination of two or more drugs
Track 5: Nuclear Pharmacy:
Nuclear pharmacy, also known as radio pharmacy, involves preparation of radioactive materials for patient administration that will be used to diagnose and treat specific diseases in nuclear medicine. It generally involves the practice of combining a radionuclide tracer with a pharmaceutical component that determines the biological localization in the patient. Radiopharmaceuticals are generally not designed to have a therapeutic effect themselves, but there is a risk to staff from radiation exposure and to patients from possible contamination in production. Due to these intersecting risks, nuclear pharmacy is a heavily regulated field. The majority of diagnostic nuclear medicine investigations are performed using Technetium.
The global nuclear medicine market size was valued at USD 6.4 billion in 2016 and is expected to exhibit a CAGR of 10.1% over the forecast period. Need for early and accurate diagnostic methods, coupled with growing demand for better therapies, is driving the market. Increasing incidence of cancer and cardiovascular disorders is also contributing toward market growth as nuclear medicine has proven rather accurate in the diagnosis and treatment of such conditions.
Track 6: Pharmacists Role In Patient Safety:
Pharmacists, also known as chemists or druggists (North American and, archaically, are health professionals who practice in pharmacy, the field of health sciences focusing on safe and effective medication use. A pharmacist is a member of the health care team directly involved with patient care. Pharmacists undergo university-level education to understand the biochemical mechanisms and actions of drugs, drug uses, therapeutic roles, side effects, potential drug interactions, and monitoring parameters. This is mated to anatomy, physiology, and pathophysiology. Pharmacists interpret and communicate this specialized knowledge to patients, physicians, and other health care providers
Track 7: Pharmacology And Toxicology:
Pharmacology is the branch of science concerned with the study of drugs and how they affect living organisms. “Drug” has a much broader meaning than that; any compound that can modify the biological function of living organisms can be considered a drug. This definition includes not only medicines that have beneficial effects in the treatment of various disorders, but also common everyday chemicals such as caffeine, nicotine and alcohol, illegal substances of abuse, and a variety of man-made or natural environmental toxins. Pharmacologists study the actions of all these substances.
The related science of toxicology involves the study of the nature and mechanisms of deleterious effects of chemicals on humans, animals and other biological systems. The study of toxicology as a distinct, yet related, discipline to pharmacology highlights the focus of toxicologists in formulating measures aimed at protecting public health against hazards associated with toxic substances in food, air and water, as well as risks that may be associated with drugs
Global in-vitro toxicology testing market is expected to reach USD 27.38 billion by 2021 from USD 14.16 billion in 2016, growing at a CAGR of 14.10% for the next five years 2016-2021. In-vitro toxicology testing is the scientific analysis of toxic effects produced by chemical substances on cultured mammalian cells or bacteria. Toxicity testing is very essential in drug discovery as identifies the toxic effects of new compound in the early stages of drug discovery. This early detection of toxicity reduces the development cost and time
Track 8: Psychiatric Pharmacy :
Psychiatric pharmacy, also known as mental health pharmacy, is the area of clinical pharmacy specializing in the treatment of people with psychiatric illnesses through the use of psychotropic medications. It is a branch of neuropsychiatric pharmacy, which includes neurologic pharmacy
Track 9: Biomedical Sciences :
Biomedical sciences are a set of applied sciences applying portions of natural science or formal science, or both, to knowledge, interventions, or technology that are of use in healthcare or public health. The field of biomedical sciences can be defined as the applied domain of life and natural sciences, used for diagnosis, prevention and treatment of human diseases. Such disciplines as medical microbiology, clinical virology, clinical epidemiology, genetic epidemiology, however, pathophysiology can be regarded as basic science.
Market analysis would be used, rather than direct examination of the gene, for several reasons: 1. The gene location is known, but the gene sequence has not yet been determined and thus cannot be analysed directly. But if markers exist close to the gene locus, then the mutant gene can be inferred through marker analysis. 2. Marker analysis is much faster analysis then directs gene sequencing. 3. Marker analysis is much cheaper than gene analysis. Marker analysis can generally be performed for under $200, while a complete screen of a gene can be several thousand dollars.
Track 10: Clinical Molecular Genetics:
Molecular genetics is the field of biology that studies the structure and function of genes at a molecular level and thus employs methods of both molecular biology and genetics. The study of chromosomes and gene expression of an organism can give insight into heredity, genetic variation, and mutations. This is useful in the study of developmental biology and in understanding and treating genetic diseases.
Track 11: Pain Management:
Pain management, pain medicine, pain control or algiatry, is a branch of medicine employing an interdisciplinary approach for easing the suffering and improving the quality of life of those living with chronic pain. The typical pain management team includes medical practitioners, pharmacists, clinical psychologists, physiotherapists, occupational therapists, physician assistants; nurses. The team may also include other mental health specialists and massage therapists. Pain sometimes resolves promptly once the underlying trauma or pathology has healed, and is treated by one practitioner, with drugs such as analgesics and (occasionally) anxiolytics. Effective management of chronic (long-term) pain, however, frequently requires the coordinated efforts of the management team.
The global pain management therapeutics market has enormous possibility for growth due to the large population that is affected by medically significant pain. The market is growing at a reasonable growth rate, driven by the cancer pain, low back pain and post-operative pain relief markets. In 2010, the global pain management therapeutics market was estimated at $28.6 billion, representing a CAGR of 5.3% between 2002 and 2010. The post-operative pain relief market, with sales of $5.9 billion in 2010, accounted for one fifth of the total pain management therapeutics market. The low back pain market, with sales of $4.9 billion, was the second largest market segment, with a share of 17% of the worldwide pain management therapeutics market. The low back pain market is followed by the cancer pain and neuropathic pain relief markets, accounting for 16% each of the global pain management therapeutics market.
Track 12: Clinical Immunology:
Immunology is a branch of biology that covers the study of immune systems in all organisms. Immunology charts, measures, and contextualizes the: physiological functioning of the immune system in states of both health and diseases; malfunctions of the immune system in immunological disorders (such as autoimmune diseases, hypersensitivities, immune deficiency, and transplant rejection, the physical, chemical and physiological characteristics of the components of the immune system in vitro, in situ, and in vivo. Immunology has applications in numerous disciplines of medicine, particularly in the fields of organ transplantation, oncology, rheumatology, virology, bacteriology, parasitology, psychiatry, and dermatology.
Track 13: General Clinical Pharmacology:
The principles of discrimination of drug therapy conjointly referred to as pharmacotherapy, may be a general term for mistreatment medication to treat illness. Pharmacogenetics is that the study of familial genetic variations in drug metabolic pathways which might have an effect on individual responses to medicine, each in terms of therapeutic result furthermore as adverse effects. And in Pharmacogenomics it deals with the influence of noni inheritable and familial genetic variation on drug response in patients by correlating organic phenomenon or single-nucleotide polymorphisms with drug absorption, distribution, metabolism and elimination, furthermore as drug receptor target effects. Pharmacokinetics and pharmacodynamics data from the scientific basis of contemporary pharmacotherapy Pharmacokinetics describes the drug concentration-time courses in body fluids ensuing from administration of an explicit drug dose, pharmacodynamics the determined result ensuing from an explicit drug concentration.
Track 14: Dispensing Pharmacy And Research Chemists:
Dispensing. Provision of drugs or medicines as set out properly on a lawful prescription. A prescription can only be filled, the drugs supplied, by a registered pharmacist, veterinarian, dentist or member of the medical profession.
Chemistry is a branch of science that involves the study of the composition, structure and properties of matter. Often known as the central science, it is a creative discipline chiefly concerned with atomic and molecular structure and its change, for instance through chemical reactions.
Track 15: Pharmaceutical And Medicinal Chemistry :
Medicinal chemistry and pharmaceutical chemistry are disciplines at the intersection of chemistry, especially synthetic organic chemistry, and pharmacology and various other biological specialties, where they are involved with design, chemical synthesis and development for market of pharmaceutical agents, or bio-active.
Track 16: Advanced Drug Delivery Research:
Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. It may involve scientific site-targeting within the body, or it might involve facilitating systemic pharmacokinetics; in any case, it is typically concerned with both quantity and duration of drug presence. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices or drug-device combination products. Drug delivery is a concept heavily integrated with dosage form and route of administration, the latter sometimes even being considered part of the definition.
Track 17: Veterinary Medicine:
Veterinary medicine is the branch of medicine that deals with the prevention, diagnosis and treatment of disease, disorder and injury in non-human animals. The scope of veterinary medicine is wide, covering all animal species, both domesticated and wild, with a wide range of conditions which can affect different species.
Veterinary medicine is widely practiced, both with and without professional supervision. Professional care is most often led by a veterinary physician (also known as a vet, veterinary surgeon or veterinarian), but also by Para veterinary workers such as veterinary nurses or technicians. This can be augmented by other paraprofessionals with specific specialisms such as animal physiotherapy or dentistry, and species relevant roles such as farriers.
Track 18: Pharmacy Practices:
Pharmacy is the science and technique of preparing and dispensing drugs. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs.
The scope of pharmacy practice includes more traditional roles such as compounding and dispensing medications, and it also includes more modern services related to health care, including clinical services, reviewing medications for safety and efficacy, and providing drug information. Pharmacists, therefore, are the experts on drug therapy and are the primary health professionals who optimize use of medication for the benefit of the patients.
Based on International Pharmaceutical Federation (FIP) the guidelines for Good Pharmaceutical Practice were first laid in 1993. And further used as reference by national pharmaceutical organisations, governments, and international pharmaceutical organizations to set up nationally accepted standards. The aim is to "contribute to health improvement and to help patients with health problems to make the best use of their medicines. This statistic shows total medicines expenditure worldwide in 2010 and 2015, and provides a forecast for 2020. In 2010, total spending on medicine was 887 billion U.S. dollars. It is estimated that until 2020 the pharmaceutical market will increase to around 1.4 trillion U.S. dollars.
Track 19: Therapeutic Drug Monitoring:
Therapeutic drug monitoring (TDM) is a branch of clinical chemistry and clinical pharmacology that specializes in the measurement of medication concentrations in blood. Its main focus is on drugs with a narrow therapeutic window. TDM aims at improving patient care by adjusting the dose of drugs for which clinical experience or clinical trials have shown it improved outcome in the general or special populations. It can be based on a priori pharmacogenetic, demographic and clinical information, and/or on the a posteriori measurement of blood concentrations of drugs (pk/pd monitoring).There are numerous variables that influence the interpretation of drug concentration data: time, route and dose of drug given, time of blood sampling, handling and storage conditions, precision and accuracy of the analytical method, validity of pharmacokinetic models and assumptions, co-medications and clinical status of the patient.
Track 20: Medication Therapy Management :
Medication Therapy Management (MTM) is medical care provided by pharmacists, or other qualified providers, the aim of which is to optimize drug therapy and improve outcomes for people taking medication, especially for people who have several chronic conditions and take several drugs to manage them, prescribed by multiple doctors.
Medication therapy management includes reviewing all the medications a person is taking and creating a single record of all them, counseling the person, and coordinating with prescribers. As of 2015 there was no good evidence that MTM created better outcomes for people or that it saved money.
Track 21: Clinical Pharmacy Specialists:
Clinical pharmacy is the branch of pharmacy in which doctor of pharmacy provide patient care that optimizes the use of medication and promotes health, wellness, and disease prevention. Clinical pharmacists care for patients in all health care settings but the clinical pharmacy movement initially began inside hospitals and clinics. Clinical pharmacists often work in collaboration with physicians, nurse practitioners, and other healthcare professionals.
Track 22: Healthcare And Hospital Management:
A hospital is a Healthcare institution provides patient treatment with specialized staff and equipment. The best known hospital is the general hospitals, which has an emergency department. Health care management uses the Electronic Medical Record System that can be record the health related information.
The global compounding pharmacy market will earn revenue of about USD 12 billion by 2022. The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
One trend in the market is increasing prevalence of hormonal imbalance. Factors such as growing geriatric population, unhealthy eating habits of people, consumption of medications, stress, and increasing prevalence of thyroid, diabetes, and tumours, are driving the rising incidences of hormonal imbalance. This also results in physical and mental issues.
According to the report, one driver in the market is increase in healthcare and pharmaceutical spending. Proportionally, pharmaceutical spending is also increasing due to the increasing demand for medications. The growing incidences of chronic diseases are encouraging the consumers to visit compounding pharmacies
The pharmaceutical industry is one of the most dynamic and complex industries, involving commercialization of cutting-edge scientific research, a huge web of stakeholders ,multi-stage supply chains, fierce competition in the race to market, and a challenging regulatory environment. The stakes are high, with each new product raising the prospect of spectacular success—or failure. Worldwide revenues are approaching $1 trillion; in the U.S. alone, marketing for pharmaceutical products is, itself, a multi-billion dollar industry. Thus pharmaceutical industry as a global sector is inarguable. A global growth rate for the Pharma industry of 6.3% CAGR through 2022, up from the 5% CAGR for the 2014-2020 periods. During the 2008-2015 period, the compound annual growth rate of global R&D spending was 1.7%; during the 2016-2022 period, the rate will grow at 2.8% Overall spending will reach $182 billion in 2022
The global market for drug discovery technologies reached nearly $39.5 billion and $46.5 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.3% to nearly $79.5 billion for the period 2014-2019. in order to earn additional margins, the pharmaceutical companies are in pursuit of blockbuster drugs, which have increased the demand for drug discovery technologies. Drug delivery technology market is projected to reach USD 1,669.40 Billion by 2021 from USD 1,179.20 Billion in 2016, at a CAGR of 7.2% during the forecast period. The global nanotechnology drug delivery market was valued at US$ 41,062.5 MN in 2014 and is projected to reach US$ 118,527.2 MN by 2023, expanding at a CAGR of 12.5% from 2015 to 2023.
The global advanced drug delivery market should grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%.The North American market should grow from nearly $75.7 billion in 2015 to $93.4 billion by 2020, a CAGR of 4.3%.
The European market should grow from roughly $57.3 billion in 2015 to nearly $72.1 billion by 2020; a CAGR of 4.7%.Asia-Pacific should grow the fastest during the forecast period with a five-year CAGR of 6.4%.
The global advanced drug delivery market is driven by development of new drugs and biologics, advances in understanding human biology and diseases, R & D spending, non-traditional administration routes and new and emerging technologies